Identification of ovarian cancer metastatic miRNAs

Serous epithelial ovarian cancer (EOC) patients often succumb to aggressive metastatic disease, yet little is known about the behavior and genetics of ovarian cancer metastasis. Here, we aim to understand how omental metastases differ from primary tumors and how these differences may influence chemo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2013-03, Vol.8 (3), p.e58226-e58226
Hauptverfasser:	Vang, Souriya, Wu, Hsin-Ta, Fischer, Andrew, Miller, Daniel H, MacLaughlan, Shannon, Douglass, Elijah, Comisar, Lauren, Steinhoff, Margaret, Collins, Colin, Smith, Peter J S, Brard, Laurent, Brodsky, Alexander S
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - pharmacology Biochemistry Biology Cancer Cancer genetics Cancer metastasis Cell cycle Cell Line, Tumor Cell survival Chemotherapy Cisplatin Cisplatin - pharmacology Comparative analysis Drug resistance Drug Resistance, Neoplasm Drug tolerance Female Gene expression Gene Expression Profiling Gene Expression Regulation, Neoplastic Genes Genetics Gynecology Humans Lesions Medical prognosis Medicine Metastases Metastasis MicroRNA MicroRNAs MicroRNAs - biosynthesis Middle Aged miRNA Molecular biology Neoplasm Metastasis Obstetrics Ovarian cancer Ovarian carcinoma Ovarian Neoplasms - metabolism Ovarian Neoplasms - pathology Patients Regulators RNA, Neoplasm - biosynthesis Spheroids, Cellular - metabolism Spheroids, Cellular - pathology Target recognition Tumors Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!